UNIVERSITY OF KENT
MODULE SPECIFICATION TEMPLATE
SECTION 1: MODULE SPECIFICATIONS
1. Title of the module
PHAR1026 Infectious Disease and Allergy Drug Discovery (adapted from PHAM1086)
2. School which will be responsible for management of the module
Medway School of Pharmacy
3. Start date of the module
Spring 2013 (1-year programme), Autumn 2013 (2-year programme)
4. The cohort of students (onwards) to which the module will be applicable
Autumn 2012 entrants
5.
20
The number of students expected to take the module
6.
Modules to be withdrawn on the introduction of this proposed module and consultation
with other relevant Schools and Faculties regarding the withdrawal
None
7. Level of the module
Level M
8. The number of credits which the module represents
15 (7.5 ECTS credits)
9. Which term(s) the module is to be taught in (or other teaching pattern)
Spring 2013 (1-year programme), Autumn 2013 (2-year programme)
10. Prerequisite and co-requisite modules
Students must have successfully completed PHAR1021 Applied Pharmacology and
PHAR1022 Translational Biology in Stage 1. In Stage 2, students must complete the
following co-requisite modules: PHAR1023 Critical Thinking, PHAR1024 Experimental
Protocol, and PHAR1025 Project Background and Design, and one of the following
modules PHAR1027 Neuroscience and Drug Discovery, PHAR1028 Renal and
Cardiovascular Drug Discovery, or PHAR1026 Infectious Disease and Allergy Drug
Discovery.
11. The programme(s) of study to which the module contributes
MSc in Applied Drug Discovery
12. The intended subject specific learning outcomes and, as appropriate, their relationship to
programme learning outcomes
After completing this module students will be able to demonstrate:
i) an ability to evaluate current research and advanced scholarship in key areas of cell
and molecular biology (A2, A4, B1, B5)
ii) a comprehensive understanding of the concepts that underpin aspects of cancer,
allergy and how microorganisms and complex microbial systems cause infection, and
understand the development of novel/alternative therapeutics in these areas (A1, A3-5,
C2-4)
iii) a systematic understanding of new developments in the therapy of important
disease states and evaluate how these methodologies may be translated into the
clinical environment (A5, B2)
New module specification approved by Faculty 20 July 2012
UNIVERSITY OF KENT
13. The intended generic learning outcomes and, as appropriate, their relationship to
programme learning outcomes
After completing this module students will be able to demonstrate:
vi) an ability to critically appraise proposed experimental strategies (B5)
vii) advanced problem solving skills relating to experimental data (D1)
viii) the ability to plan and formulate accurate and concise communications to convey
principles of scientific theories and ideas using a range of media (D2)
ix) advanced numeric and statistical skills to inform the analysis and interpretation of
scientific data (D3)
x) a comprehensive range of study skills to support self directed learning (D6)
14. A synopsis of the curriculum
The aim of this module is to give students a comprehensive understanding and
knowledge of current problems and new insights into cell and molecular biology. The
course will cover the impact of new research on our understanding of fundamental
biological processes that relate to diseases such as cancer. The emphasis of this
module is how basic science is translated into diagnostics and therapy; past, present
and future. The indicative content will include: (a) Novel Cancer Therapy: anticancer
pro-drugs and gene therapy; (b) Immunology and Microbiology; (c) Allergic
Inflammation; (d) Translational Virology.
15. Indicative Reading List
Students will be directed as appropriate to primary literature and reviews available
from journal collections in Kent or Greenwich.
16. Learning and Teaching Methods, including the nature and number of contact hours and
the total study hours which will be expected of students, and how these relate to
achievement of the intended learning outcomes
1-year programme:
The module comprises approximately 30 scheduled lecture hours and 30 tutorial and
workshop hours. Total study hours are 150; the remaining 90 hours being made up of
self-directed e-learning tasks (including forums) and self-directed learning. Each
element of the module (a – d above) is taught separately.
2-year programme:
Online e-learning in a storyboard format (the equivalent of lectures in the 1-year
programme) is intended to present the key information directly relating to the learning
objectives (60 hours; 15 hours per element [a – d]). E-activities (30 hours) serve to
reinforce materials taught via the storyboard format. Total study hours are 150; the
remaining 60 hours being made up of self-directed learning tasks, self-directed
learning, and additional e-activities to replace tutorials of the 1-year programme. As
with the 1-year programme, each element of the module (a – d above) is taught
separately.
17. Assessment methods and how these relate to testing achievement of the intended
learning outcomes
Assignment (50%) (A1, 2 and 5, B1 and 5, C2-4, D2, 3 and 6)
E-activities (2x problem-based learning tasks and 10 MCQ questions) (50%) (A1-5, B1, 2
and 5, D1-3 and 6)
All module learning outcomes are tested by the above.
18. Implications for learning resources, including staff, library, IT and space
An emphasis is placed on self-directed reading and study, however this should not
significantly impact library resources. The programme is supported by Moodle and
myFolio, however this should not significantly impact IT resources.
19. The School recognises and has embedded the expectations of current disability
equality legislation, and supports students with a declared disability or special
educational need in its teaching. Within this module we will make reasonable
adjustments wherever necessary, including additional or substitute materials,
New module specification approved by Faculty 20 July 2012
UNIVERSITY OF KENT
teaching modes or assessment methods for students who have declared and
discussed their learning support needs. Arrangements for students with declared
disabilities will be made on an individual basis, in consultation with the
University’s disability/dyslexia support service, and specialist support will be
provided where needed.
SECTION 2: MODULE IS PART OF A PROGRAMME OF STUDY IN A UNIVERSITY
SCHOOL
Statement by the School Director of Learning and Teaching/School Director of
Graduate Studies (as appropriate): "I confirm I have been consulted on the above module
proposal and have given advice on the correct procedures and required content of module
proposals"
................................................................
..............................................
Director of Learning and Teaching/Director of Graduate
Studies (delete as applicable)
Date
…………………………………………………
Print Name
Statement by the Head of School: "I confirm that the School has approved the introduction
of the module and, where the module is proposed by School staff, will be responsible for its
resourcing"
.................................................................
..............................................
Head of School
Date
…………………………………………………….
Print Name
SECTION 3: MODULE IS PART OF A PROGRAMME IN A PARTNER COLLEGE OR
VALIDATED INSTITUTION
(Where the module is proposed by a Partner College/Validated Institution)
Statement by the Nominated Officer of the College/Validated Institution (delete as
applicable): "I confirm that the College/Validated Institution (delete as applicable) has
approved the introduction of the module and will be responsible for its resourcing"
.................................................................
Nominated Responsible Officer
College/Validated Institution
of
..............................................
Partner
New module specification approved by Faculty 20 July 2012
Date
UNIVERSITY OF KENT
………………………………………………….
Print Name
…………………………………………………..
Post
………………………………………….
Partner College/Validated Institution
Module Specification Template
Last updated July 2010
New module specification approved by Faculty 20 July 2012